These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34547306)
1. Cationic Polymeric Nanoparticles for Improved Ocular Delivery and Antimycotic Activity of Terconazole. Mohsen AM J Pharm Sci; 2022 Feb; 111(2):458-468. PubMed ID: 34547306 [TBL] [Abstract][Full Text] [Related]
2. Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: Elhabal SF; Ghaffar SA; Hager R; Elzohairy NA; Khalifa MM; Mohie PM; Gad RA; Omar NN; Elkomy MH; Khasawneh MA; Abdelaal N Int J Pharm X; 2023 Dec; 5():100174. PubMed ID: 36908304 [TBL] [Abstract][Full Text] [Related]
3. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits. Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH AAPS PharmSciTech; 2013 Jun; 14(2):782-93. PubMed ID: 23615773 [TBL] [Abstract][Full Text] [Related]
4. Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation. Yousry C; Zikry PM; Salem HM; Basalious EB; El-Gazayerly ON Drug Deliv Transl Res; 2020 Jun; 10(3):801-814. PubMed ID: 31989414 [TBL] [Abstract][Full Text] [Related]
5. Fabrication of Highly Deformable Bilosomes for Enhancing the Topical Delivery of Terconazole: In Vitro Characterization, Microbiological Evaluation, and In Vivo Skin Deposition Study. Mosallam S; Sheta NM; Elshafeey AH; Abdelbary AA AAPS PharmSciTech; 2021 Feb; 22(2):74. PubMed ID: 33586022 [TBL] [Abstract][Full Text] [Related]
6. Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation. Mosallam S; Ragaie MH; Moftah NH; Elshafeey AH; Abdelbary AA Int J Nanomedicine; 2021; 16():119-132. PubMed ID: 33447031 [TBL] [Abstract][Full Text] [Related]
7. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B. Zhou W; Wang Y; Jian J; Song S Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427 [TBL] [Abstract][Full Text] [Related]
8. Biodegradable Polymers-based Nanoparticles to Enhance the Antifungal Efficacy of Fluconazole against Saleh N; Elshaer S; Girgis G Curr Pharm Biotechnol; 2022; 23(5):749-757. PubMed ID: 34238149 [TBL] [Abstract][Full Text] [Related]
9. Anticandidal activities of terconazole, a broad-spectrum antimycotic. Tolman EL; Isaacson DM; Rosenthale ME; McGuire JL; Van Cutsem J; Borgers M; Van den Bossche H Antimicrob Agents Chemother; 1986 Jun; 29(6):986-91. PubMed ID: 3729366 [TBL] [Abstract][Full Text] [Related]
10. Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration. Huang PH; Hu SC; Lee CW; Yeh AC; Tseng CH; Yen FL Int J Nanomedicine; 2016; 11():1615-27. PubMed ID: 27143883 [TBL] [Abstract][Full Text] [Related]
11. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery. Gandhi A; Jana S; Sen KK Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259 [TBL] [Abstract][Full Text] [Related]
12. A stepwise optimization strategy to formulate Elmotasem H; Awad GEA Asian J Pharm Sci; 2020 Sep; 15(5):617-636. PubMed ID: 33193864 [TBL] [Abstract][Full Text] [Related]
13. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Katara R; Majumdar DK Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566 [TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro characterization of poly(dl-lactide-co-glycolide)/Eudragit RLPO or RS30D nanoparticles as an oral carrier of levofloxacin hemihydrate. Hasan AA; Sabry SA; Abdallah MH; El-Damasy DA Pharm Dev Technol; 2016 Sep; 21(6):655-63. PubMed ID: 25915180 [TBL] [Abstract][Full Text] [Related]
16. Terconazole. Pharmacology of a new antimycotic agent. Cauwenbergh G; Vanden Bossche H J Reprod Med; 1989 Aug; 34(8 Suppl):588-92. PubMed ID: 2677363 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic. Isaacson DM; Tolman EL; Tobia AJ; Rosenthale ME; McGuire JL; Vanden Bossche H; Janssen PA J Antimicrob Chemother; 1988 Mar; 21(3):333-43. PubMed ID: 3129389 [TBL] [Abstract][Full Text] [Related]
18. Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery. Abd-Elsalam WH; El-Zahaby SA; Al-Mahallawi AM Drug Deliv; 2018 Nov; 25(1):484-492. PubMed ID: 29411650 [TBL] [Abstract][Full Text] [Related]